No description yet.
Rockville, MDFounded 200550 employees
1 source · checked 1 time, last 2d ago
The filing lists $8,000,000 as the total offering amount, but $6,494,308 as total amount sold; the amount uses sold proceeds.; not on the page it cites, so not applied: date
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Form D (equity) [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $6.5M | 2026-10-30 | not stated | No recent discussion |
1 source · checked 1 time, last 2d ago [ VERIFIED ] read against 1 source The filing lists $8,000,000 as the total offering amount, but $6,494,308 as total amount sold; the amount uses sold proceeds.; not on the page it cites, so not applied: date [ BUILT WITH ]·[ SEARCH ]from a Form D filing·[ SCRAPE ]1 page read: sec.gov·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Series A | $15 million | 2021-04-02 | Simcah Management | |
Cellphire develops stabilized platelet-derived therapeutics for clinicians treating serious bleeding in trauma, surgery, critical care and veterinary medicine.
None named.
Also named as backers in company research: Simcah Management, Biomedical Advanced Research and Development Authority (BARDA), U.S. Army Medical Research and Development Command